33 research outputs found
TyG Index change is more determinant for forecasting type 2 diabetes onset than weight gain
Abstract: The risk of type 2 diabetes associated with obesity appears
to be influenced by other metabolic abnormalities, and there is controversy
about the harmless condition of the metabolically healthy obese
(MHO) state. The aim of this study is to assess the risk of diabetes and
the impact of changes in weight and in triglyceride-glucose index (TyG
index), according to the metabolic health and obesity states.
We analyzed prospective data of the Vascular Metabolic CUN
cohort, a population-based study among a White European population
(mean follow-up, 8.9 years). Incident diabetes was assessed in 1923
women and 3016 men with a mean age at baseline of 55.33 13.68 and
53.78 12.98 years old.
A Cox proportional-hazard analysis was conducted to estimate the
hazard ratio (HR) of diabetes on metabolically healthy nonobese
(MHNO), metabolically healthy obese, metabolically unhealthy nonobese
(MUNO), and metabolically unhealthy obese (MUO). A continuous
standardized variable (z-score) was derived to compute the HR
for diabetes per 1-SD increment in the body mass index (BMI) and the
TyG index.
MHO, MUNO, and MUO status were associated with the development
of diabetes, HR of 2.26 (95% CI: 1.25–4.07), 3.04 (95% CI: 1.69–
5.47), and 4.04 (95% CI: 2.14–7.63), respectively. MUNO individuals
had 1.82 greater risk of diabetes compared to MHO subjects (95% CI:
1.04–3.22). The HRs for incident diabetes per 1-SD increment in BMI
and TyG indexes were 1.23 (95% CI: 1.04–1.44) and 1.54 (95% CI:
1.40–1.68). The increase in BMI did not raise the risk of developing
diabetes among metabolically unhealthy subjects, whereas increasing
the TyG index significantly affect the risk in all metabolic health
categories.
Metabolic health is more important determinant for diabetes onset
than weight gain. The increase in weight does not raise the risk of
developing diabetes among metabolically unhealthy subjects
The ancient evolutionary history of polyomaviruses
Author Summary: Polyomaviruses are a family of DNA-based viruses that are known to infect various terrestrial vertebrates, including humans. In this report, we describe our discovery of highly divergent polyomaviruses associated with various marine fish. Searches of public deep sequencing databases unexpectedly revealed the existence of polyomavirus-like sequences in scorpion and spider datasets. Our analysis of these new sequences suggests that polyomaviruses have slowly co-evolved with individual host animal lineages through an established mechanism known as intrahost divergence. The proposed model is similar to the mechanisms through with other DNA viruses, such as papillomaviruses, are thought to have evolved. Our analysis also suggests that distantly related polyomaviruses sometimes recombine to produce new chimeric lineages. We propose a possible taxonomic scheme that can account for these inferred ancient recombination events
The C-terminal domain Of ParB Is critical for dynamic DNA binding and bridging interactions which condense the bacterial centromere
The ParB protein forms DNA bridging interactions around parS to form networks which condense DNA and earmark the bacterial chromosome for segregation. The mechanism underlying the formation of ParB nucleoprotein complexes is unclear. We show here that the central DNA binding domain is essential for anchoring at parS, and that this interaction is not required for DNA condensation. Structural analysis of the C-terminal domain reveals a dimer with a lysine-rich surface that binds DNA non-specifically and is essential for DNA condensation in vitro. Mutation of either the dimerisation or the DNA binding interface eliminates ParB foci formation in vivo. Moreover, the free C-terminal domain can rapidly decondense ParB networks independently of its ability to bind DNA. Our work reveals a dual role for the C-terminal domain of ParB as both a DNA binding and bridging interface, and highlights the dynamic nature of ParB networks
Newly developed Learning and Verbal Memory Test (TAMV-I): Normative data for Spanish-speaking pediatric population
OBJECTIVE: To generate normative data for the Learning and Verbal Memory Test (TAMV-I) in Spanish-speaking pediatric populations. METHOD: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Guatemala, Honduras, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the TAMV-I as part of a larger neuropsychological battery. Free recall, memory delay and recognition scores were normed using multiple linear regressions and standard deviations of residual values. Age, age2, sex, and mean level of parental education (MLPE) were included as predictors in the analyses. RESULTS: The final multiple linear regression models indicated main effects for age on all scores, such that scores increased linearly as a function of age. Age2 had a significant effect in all countries except Cuba, and Puerto Rico for free recall score; a significant effect for memory delay score in all countries except Cuba and Puerto Rico; and a significant effect for recognition score in in all countries except Guatemala, Honduras, and Puerto Rico. Models showed an effect for MLPE in Chile (free recall), Honduras (free recall), Mexico (free recall), Puerto Rico (free recall, memory delay, and recognition), and Spain (free recall and memory delay). Sex affected free recall score for Cuba, Ecuador, Guatemala, Mexico, Paraguay, Peru, and Spain, memory delay score for all countries except Chile, Paraguay, and Puerto Rico, and recognition score for Ecuador, Mexico, Peru, and Spain, with girls scoring higher than boys. CONCLUSIONS: This is the largest Spanish-speaking pediatric normative study in the world, and it will allow neuropsychologists from these countries to have a more accurate way to interpret the TAMV-I with pediatric populations
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent Attention-Deficit/Hyperactivity Disorder and substance use disorder
Education and Child Studie
International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004-2009
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia). Copyright © 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved
Análisis de subpoblaciones monocitarias y su asociación con el riesgo cardiovascular. Hallazgo de nuevos biomarcadores séricos: SDF1 y MMP-12
En la actualidad, la prevalencia de las enfermedades cardiovasculares (ECV) es
de 108,7 millones de personas, presentando una incidencia anual de 19,9
millones de casos nuevos en la Unión Europea (UE), siendo mayor en mujeres.
A día de hoy las ECV siguen siendo la principal causa de muerte en los países
miembros de la UE, sumando un total de 2,2 millones en mujeres y 1,9 millones
en hombres, lo que representa un 47% y 39% de las muertes totales
respectivamente (1). En nuestro país, las ECV también representan la principal
causa de mortalidad con aproximadamente 120.000 muertes al año, siendo la
razón de una de cada 4 muertes en varones y una de cada 3 en mujeres. Si bien,
en varones la enfermedad coronaria aguda encabeza la lista, en mujeres lo
presenta el accidente cerebrovascular (2)
Análisis de subpoblaciones monocitarias y su asociación con el riesgo cardiovascular. Hallazgo de nuevos biomarcadores séricos: SDF1 y MMP-12
En la actualidad, la prevalencia de las enfermedades cardiovasculares (ECV) es
de 108,7 millones de personas, presentando una incidencia anual de 19,9
millones de casos nuevos en la Unión Europea (UE), siendo mayor en mujeres.
A día de hoy las ECV siguen siendo la principal causa de muerte en los países
miembros de la UE, sumando un total de 2,2 millones en mujeres y 1,9 millones
en hombres, lo que representa un 47% y 39% de las muertes totales
respectivamente (1). En nuestro país, las ECV también representan la principal
causa de mortalidad con aproximadamente 120.000 muertes al año, siendo la
razón de una de cada 4 muertes en varones y una de cada 3 en mujeres. Si bien,
en varones la enfermedad coronaria aguda encabeza la lista, en mujeres lo
presenta el accidente cerebrovascular (2)